Zifeng Yang

InstitutionGuangzhou Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 25 Covid-19 publications, with a maximum of 4 publications in August 2020
    All Publications
    Bar chart showing 123 publications over 16 distinct years, with a maximum of 24 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hua C, Ma Q, Zhu Y, Xia S, Liu Z, Li L, Lu L, Zhong N, Liu S, Yang Z, Jiang S. Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther. 2021 08 26; 6(1):318. PMID: 34446694.
      Citations: 1     Translation:Humans
    2. Zhang D, Hamdoun S, Chen R, Yang L, Ip CK, Qu Y, Li R, Jiang H, Yang Z, Chung SK, Liu L, Wong VKW. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res. 2021 10; 172:105820. PMID: 34403732.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    3. Ma Q, Xie Y, Wang Z, Lei B, Chen R, Liu B, Jiang H, Wang Y, Liu Q, Yang Z. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. J Ethnopharmacol. 2021 Oct 28; 279:114367. PMID: 34174375.
      Citations: 1     Fields:    Translation:HumansCells
    4. Xu X, Zhang J, Zheng W, Yang Z, Zhao X, Wang C, Su H, Zhao L, Xue L, Hu F, Xu X, Wen M, Liao J, Zeng Z, Wang L, Zeng J, Guo Y, Li B, Liu Q. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study. Ann Palliat Med. 2021 May; 10(5):5146-5155. PMID: 33894725.
      Citations: 3     Fields:    Translation:Humans
    5. Zheng B, Yuan M, Ma Q, Wang S, Tan Y, Xu Y, Ye J, Gao Y, Sun X, Yang Z, Xu P, Kong L, Wu X, Xu Q. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues. Int Immunopharmacol. 2021 Jun; 95:107567. PMID: 33756225.
      Citations: 2     Fields:    Translation:HumansCells
    6. Yang Z, Zeng Z, Wang K, Zhong N, He J. Scientific guidance to fight the pandemic: the Coronavirus Disease 2019 (COVID-19). J Thorac Dis. 2021 Feb; 13(2):505-510. PMID: 33717523.
      Citations: 1     
    7. Liang T, Qiu J, Niu X, Ma Q, Zhou C, Chen P, Zhang Q, Chen M, Yang Z, Liu S, Li L. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor. Front Pharmacol. 2020; 11:603830. PMID: 33519467.
      Citations: 1     
    8. Cheng LL, Guan WJ, Duan CY, Zhang NF, Lei CL, Hu Y, Chen AL, Li SY, Zhuo C, Deng XL, Cheng FJ, Gao Y, Zhang JH, Xie JX, Peng H, Li YX, Wu XX, Liu W, Peng H, Wang J, Xiao GM, Chen PY, Wang CY, Yang ZF, Zhao JC, Zhong NS. Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):71-78. PMID: 32910179.
      Citations: 17     Fields:    Translation:HumansCells
    9. Sun J, Zhu A, Li H, Zheng K, Zhuang Z, Chen Z, Shi Y, Zhang Z, Chen SB, Liu X, Dai J, Li X, Huang S, Huang X, Luo L, Wen L, Zhuo J, Li Y, Li Y, Wang Y, Zhang L, Zhang Y, Li F, Feng L, Chen X, Zhong N, Yang Z, Huang J, Zhao J, Li YM. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020 Dec; 9(1):991-993. PMID: 32342724.
      Citations: 112     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Zhang Z, Zhang L, Zhu A, Wang Y, Guan W, Zeng Z, Sun J, Li F, Zhao J, Yang Z, Zhao J, Zhong N. Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model. J Thorac Dis. 2020 Dec; 12(12):7454-7466. PMID: 33447433.
      Citations:    
    11. Zhong NS, Yang ZF, Jiang M, Liang JY. A Potential Chinese Medicine Granule Suppressing ARDS of COVID-19: Keguan-1. Chin J Integr Med. 2020 11; 26(11):803-804. PMID: 33017033.
      Citations:    Fields:    Translation:HumansPHPublic Health
    12. Choudhry N, Zhao X, Xu D, Zanin M, Chen W, Yang Z, Chen J. Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). J Med Chem. 2020 11 25; 63(22):13205-13227. PMID: 32845145.
      Citations: 8     Fields:    Translation:Humans
    13. Xiao C, Ling S, Qiu M, Deng Z, Chen L, Zhu A, Chen Y, Liu Y, Lin X, Lin F, Wu Q, Shen L, Ye F, Liu X, Li Y, Zhao J, Yang Z, Cowling BJ, Webby R, Zanin M, Wong SS. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2. Influenza Other Respir Viruses. 2021 01; 15(1):7-12. PMID: 32844604.
      Citations: 4     Fields:    Translation:HumansCells
    14. Zhao J, Zhou H, Huang W, Zhou J, Qiu M, Deng Z, Chen L, Weng Y, Cai L, Gu Y, Zheng Q, Chen Q, Hou X, Wang L, Shen L, Yang Z. Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy. J Thorac Dis. 2020 Aug; 12(8):4368-4373. PMID: 32944349.
      Citations: 4     
    15. Yang Z, Wu J, Ye F, Zhu B, Guan W, Huang J, Songyang Z, Liu Y, Chen Y, Du Q, Chen J, Zhang Y, Ke C, Lin Y, Sun B, Zeng J, Chen L, Ren J, Jiang X, Yu M, Di B, Zhong N, Zheng L. Expert consensus-based laboratory testing of SARS-CoV-2. J Thorac Dis. 2020 Aug; 12(8):4378-4390. PMID: 32944351.
      Citations: 1     
    16. Ma Q, Li R, Pan W, Huang W, Liu B, Xie Y, Wang Z, Li C, Jiang H, Huang J, Shi Y, Dai J, Zheng K, Li X, Hui M, Fu L, Yang Z. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-?B) signaling pathway. Phytomedicine. 2020 Nov; 78:153296. PMID: 32890913.
      Citations: 15     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. Liang W, Lin Y, Bi J, Li J, Liang Y, Wong SS, Zanin M, Yang Z, Li C, Zhong R, Jiang G, Han G, Hu D, He J, Zhong N. Serosurvey of SARS-CoV-2 among hospital visitors in China. Cell Res. 2020 09; 30(9):817-818. PMID: 32686766.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    18. Lei H, Ye F, Liu X, Huang Z, Ling S, Jiang Z, Cheng J, Huang X, Wu Q, Wu S, Xie Y, Xiao C, Ye D, Yang Z, Li Y, Leung NHL, Cowling BJ, He J, Wong SS, Zanin M. SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients. Influenza Other Respir Viruses. 2020 11; 14(6):688-699. PMID: 32578948.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    19. Ma Q, Qiu M, Zhou H, Chen J, Yang X, Deng Z, Chen L, Zhou J, Liao Y, Chen Q, Zheng Q, Cai L, Shen L, Yang Z. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Pharmacol Res. 2020 10; 160:105073. PMID: 32653650.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    20. Guan WD, Chen LP, Ye F, Ye D, Wu SG, Zhou HX, He JY, Yang CG, Zeng ZQ, Wang YT, Li RF, Du QL, Liang XL, Ma QH, Yang ZF. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction. Chin Med J (Engl). 2020 06 05; 133(11):1385-1386. PMID: 32149770.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    21. Huang Y, Chen S, Yang Z, Guan W, Liu D, Lin Z, Zhang Y, Xu Z, Liu X, Li Y. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients. Am J Respir Crit Care Med. 2020 06 01; 201(11):1435-1438. PMID: 32293905.
      Citations: 73     Fields:    Translation:HumansCellsPHPublic Health
    22. Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine. 2021 May; 85:153242. PMID: 33867046.
      Citations: 120     Fields:    Translation:Humans
    23. Wang X, Zhong M, Liu Y, Ma P, Dang L, Meng Q, Wan W, Ma X, Liu J, Yang G, Yang Z, Huang X, Liu M. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER. Sci Bull (Beijing). 2020 Sep 15; 65(17):1436-1439. PMID: 32373393.
      Citations: 40     
    24. Ma Q, Pan W, Li R, Liu B, Li C, Xie Y, Wang Z, Zhao J, Jiang H, Huang J, Shi Y, Dai J, Zheng K, Li X, Yang Z. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-?B signaling pathway. Pharmacol Res. 2020 08; 158:104850. PMID: 32360580.
      Citations: 30     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    25. Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, Liu P, Cao X, Gao Z, Mai Z, Liang J, Liu X, Li S, Li Y, Ye F, Guan W, Yang Y, Li F, Luo S, Xie Y, Liu B, Wang Z, Zhang S, Wang Y, Zhong N, He J. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020 Mar; 12(3):165-174. PMID: 32274081.
      Citations: 293     
    26. Zhan Y, Yang Z, Chen R, Wang Y, Guan W, Zhao S. Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls. BMC Pulm Med. 2014 Sep 02; 14:144. PMID: 25178477.
      Citations: 10     Fields:    Translation:HumansCells
    Yang's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (348)
    Explore
    _
    Co-Authors (291)
    Explore
    _
    Similar People (60)
    Explore
    _